Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Enterprise Value (2014 - 2026)

Scynexis' (SCYX) quarterly Enterprise Value came in at -$74.2 million in Q2 2026, down 58.9% on a YoY basis from -$180.5 million in Q2 2025, and down 53.72% quarter-over-quarter from -$48.3 million in Q1 2026.

Analysis

Scynexis (SCYX) Enterprise Value (2014 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Enterprise Value for 13 consecutive years, with -$74.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Enterprise Value fell 58.9% year-over-year to -$74.2 million; the trailing twelve-month figure through Jun 2026 stood at -$74.2 million (down 58.9% YoY), and the FY2025 full-year result was -$12.5 million, down 1985.59% from the prior year.
  • Enterprise Value fell to -$74.2 million in Q2 2026 per SCYX's latest filing, from -$48.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $60.6 million in Q1 2023 and bottomed at -$74.2 million in Q2 2026.
  • Historically, Enterprise Value has averaged -$20.4 million across 5 years, with a median of -$31.2 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 560.44% in 2023, then slumped 1985.59% in 2025.
  • Over 5 years, Enterprise Value stood at -$7.0 million in 2022, then soared by 560.44% to $32.3 million in 2023, then slumped by 101.85% to -$599181.0 in 2024, then plunged by 1985.59% to -$12.5 million in 2025, then slumped by 493.78% to -$74.2 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$74.2 million, -$48.3 million, and -$12.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -74.20 Mn
Mar 31, 2026 -48.27 Mn
Dec 31, 2025 -12.50 Mn
Sep 30, 2025 -28.72 Mn
Jun 30, 2025 -46.70 Mn
Mar 31, 2025 -40.40 Mn
Dec 31, 2024 -599,181.03
Sep 30, 2024 -52.56 Mn
Jun 30, 2024 -33.72 Mn
Mar 31, 2024 -68.04 Mn
Dec 31, 2023 32.35 Mn
Sep 30, 2023 -40.01 Mn
Jun 30, 2023 21.58 Mn
Mar 31, 2023 60.56 Mn
Dec 31, 2022 -7.03 Mn
Sep 30, 2022 -9.56 Mn
Jun 30, 2022 -38.19 Mn
Mar 31, 2022 19.04 Mn
Dec 31, 2021 70.62 Mn
Sep 30, 2021 26.48 Mn